The American people have spoken and elected Donald Trump and JD Vance as our next President and Vice President. The HIV+Hepatitis Policy Institute will work with the new administration on furthering efforts to end HIV and hepatitis in the United States. With proper leadership, policies, and funding, we can end both these infectious diseases.
“While we appreciate the sustained funding for many domestic HIV and hepatitis programs, we are devastated by the proposal to virtually eliminate the Ending the HIV Epidemic initiative,” said Carl Schmid, executive director of the HIV+Hepatitis Policy Institute. “We were on a trajectory to end HIV by ensuring all people have access to care and treatment, and prevent new infections through increasing access to PrEP, but now all those efforts will be lost. This bill cannot stand as is.”
Washington DC… In the final hours of the Trump administration, Seema Verma, former administrator of the Centers for Medicare and Medicaid Services (CMS), announced a Medicare Part D demonstration project…
Washington DC… The HIV+Hepatitis Policy Institute applauds the release of the HIV National Strategic Plan: A Roadmap to End the Epidemic by the U.S. Department of Health and Human Services…
Washington DC… Today, the Trump administration rushed out the partial release of the rules that govern how private health plans must operate in 2022 and in doing so…